HTA for Orphan Medicinal Products (OMPs)

£20.00(per ticket)

No account? Please purchase this event to watch on-demand

Dr Chris Skedgel
Director | OHE

Associated Masterclass: Innovation for Small Populations: What Should We Pay for?

Lecture duration: 19:32

  • Are health conditions been salami-sliced to drive exceptionalism?
  • Can evidence in support of Health Technology Assessment (HTA) submissions for OMPs meet the same standards as medicines for more common conditions?
  • What is society willingness to prioritise treatments for rare conditions?

Select required number of tickets: